IMAB-027-vcMMAE

N/A

Report date: 2025/12/10 11:17:57

Base Information

Drug NameIMAB-027-vcMMAE

Drug Alias NameIMAB 027-monomethyl auristatin EIMAB 027/monomethyl auristatin E

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > VC linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionTubulin inhibitorsTubulin polymerisation inhibitorsMitosis inhibitors +[5]

TargetsTubulinClaudin 6

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGanymed Pharmaceuticals Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesGanymed Pharmaceuticals Gmbh

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A